We are live on ! Find out more
ALXA

Alexza Pharmaceuticals Inc
ALXA

Delisted

ALXA was delisted on the 16th of June, 2016.

Back to rankings

Fund managers haven’t disclosed any holdings of ALXA yet.

ALXA Hedge Fund Activity: Q2 2016 in Review

0 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q2 2016, worth a combined $0 — down 100% from $1.45M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ALXA and 0 opened new positions — a net loss of 25 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $379K sold.

  • 0 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q2 2016, down from 25 in Q1 2016.
  • Funds reported $0 of Alexza Pharmaceuticals Inc stock for Q2 2016, down 100% quarter-over-quarter.
  • 0 funds opened new Alexza Pharmaceuticals Inc positions in Q2 2016 and 25 closed out, a net change of -25 holders.
  • The largest Alexza Pharmaceuticals Inc seller in Q2 2016 was Morgan Stanley, an estimated $379K sold.

Based on aggregated 13F filings for Q2 2016.